The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Platelets in atherosclerosis
Abstract
Summary: Beyond obvious functions in haemostasis and thrombosis, platelets are considered to be essential in proinflammatory surroundings such as atherosclerosis, allergy, rheumatoid arthritis and even cancer. In atherosclerosis, platelets facilitate the recruitment of inflammatory cells towards the lesion sites and release a plethora of inflammatory mediators, thereby enriching and boosting the inflammatory milieu. Platelets do so by interacting with endothelial cells, circulating leukocytes (monocytes, neutrophils, dendritic cells, T-cells) and progenitor cells. This cross-talk enforces leukocyte activation, adhesion and transmigration. Furthermore, platelets are known to function in innate host defense through the release of antimicrobial peptides and the expression of pattern recognition receptors. In severe sepsis, platelets are able to trigger the formation of neutrophil extracellular traps (NETs), which bind and clear pathogens. The present antiplatelet therapies that target key pathways of platelet activation and aggregation therefore hold the potential to modulate platelet-derived immune functions by reducing cellular interactions of platelets with other immune components and by reducing the secretion of inflammatory proteins into the milieu. The objective of this review is to update and discuss the current perceptions of the platelet immune constituents and their prospect as therapeutic targets in an atherosclerotic setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
Henn, V., Slupsky, J. R., Gräfe, M., Anagnostopoulos, I., Förster, R., Müller-Berghaus, G., & Kroczek, R. A. (1998) · Nature · doi:10.1038/35393 · Cited by 2,078
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Mechanisms of Thrombus Formation
Furie, B., & Furie, B. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801082 · Cited by 1,926
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
Platelets and the immune continuum
Semple, J. W., Italiano, J. E., & Freedman, J. (2011) · Nature Reviews Immunology · doi:10.1038/nri2956 · Cited by 1,692
Assoian, R. K., Komoriya, A., Meyers, C. A., Miller, D. M., & Sporn, M. B. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32345-7 · Cited by 1,598
Platelets in inflammation and atherogenesis
Gawaz, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27196 · Cited by 1,468
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
Schall, T. J., Bacon, K., Toy, K. J., & Goeddel, D. V. (1990) · Nature · doi:10.1038/347669a0 · Cited by 1,379
Natural regulatory T cells control the development of atherosclerosis in mice
Ait-Oufella, H., Salomon, B. L., Potteaux, S., Robertson, A.-K. L., Gourdy, P., Zoll, J., Merval, R., Esposito, B., Cohen, J. L., Fisson, S., et al. (2006) · Nature Medicine · doi:10.1038/nm1343 · Cited by 1,100
Myocardial Infarction Genetics Consortium (2009) · Nature Genetics · doi:10.1038/ng.327 · Cited by 1,088
Febbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K., & Silverstein, R. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9259 · Cited by 1,044
Toll-like Receptor 4 Polymorphisms and Atherogenesis
Kiechl, S., Lorenz, E., Reindl, M., Wiedermann, C. J., Oberhollenzer, F., Bonora, E., Willeit, J., & Schwartz, D. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012673 · Cited by 1,024
Michelsen, K. S., Wong, M. H., Shah, P. K., Zhang, W., Yano, J., Doherty, T. M., Akira, S., Rajavashisth, T. B., & Arditi, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403249101 · Cited by 1,019
Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E
Huo, Y., Schober, A., Forlow, S. B., Smith, D. F., Hyman, M. C., Jung, S., Littman, D. R., Weber, C., & Ley, K. (2003) · Nature Medicine · doi:10.1038/nm810 · Cited by 1,005
A dual thrombin receptor system for platelet activation
Kahn, M. L., Zheng, Y.-W., Huang, W., Bigornia, V., Zeng, D., Moff, S., Farese, R. V., Tam, C., & Coughlin, S. R. (1998) · Nature · doi:10.1038/29325 · Cited by 979
A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation
Massberg, S., Brand, K., Grüner, S., Page, S., Müller, E., Müller, I., Bergmeier, W., Richter, T., Lorenz, M., Konrad, I., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012044 · Cited by 879
A shear gradient–dependent platelet aggregation mechanism drives thrombus formation
Nesbitt, W. S., Westein, E., Tovar-Lopez, F. J., Tolouei, E., Mitchell, A., Fu, J., Carberry, J., Fouras, A., & Jackson, S. P. (2009) · Nature Medicine · doi:10.1038/nm.1955 · Cited by 862
Edfeldt, K., Swedenborg, J., Hansson, G. K., & Yan, Z.-Q. (2002) · PubMed · Cited by 847
Soluble CD40 Ligand in Acute Coronary Syndromes
Heeschen, C., Dimmeler, S., Hamm, C. W., van den Brand, M. J., Boersma, E., Zeiher, A. M., & Simoons, M. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022600 · Cited by 828
Platelets, inflammation and tissue regeneration
Nurden, A. (2011) · Thrombosis and Haemostasis · doi:10.1160/ths10-11-0720 · Cited by 791
Adhesion Mechanisms in Platelet Function
Ruggeri, Z. M., & Mendolicchio, G. L. (2007) · Circulation Research · doi:10.1161/01.res.0000267878.97021.ab · Cited by 755
CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism
André, P., Prasad, K. S. S., Denis, C. V., He, M., Papalia, J. M., Hynes, R. O., Phillips, D. R., & Wagner, D. D. (2002) · Nature Medicine · doi:10.1038/nm0302-247 · Cited by 726
Edfeldt, K., Swedenborg, J., Hansson, G. K., & Yan, Z.-Q. (2002) · Circulation · doi:10.1161/circ.105.10.1158 · Cited by 707
Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis
Drechsler, M., Megens, R. T. A., van Zandvoort, M., Weber, C., & Soehnlein, O. (2010) · Circulation · doi:10.1161/circulationaha.110.961714 · Cited by 698
Cell Adhesion Mechanisms in Platelets
Varga-Szabo, D., Pleines, I., & Nieswandt, B. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.150474 · Cited by 588
RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic Endothelium
von Hundelshausen, P., Weber, K. S. C., Huo, Y., Proudfoot, A. E. I., Nelson, P. J., Ley, K., & Weber, C. (2001) · Circulation · doi:10.1161/01.cir.103.13.1772 · Cited by 584
Platelet functions beyond hemostasis
SMYTH, S. S., MCEVER, R. P., WEYRICH, A. S., MORRELL, C. N., HOFFMAN, M. R., AREPALLY, G. M., FRENCH, P. A., DAUERMAN, H. L., & BECKER, R. C. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03586.x · Cited by 584
Nuclear Factor κB Signaling in Atherogenesis
de Winther, M. P. J., Kanters, E., Kraal, G., & Hofker, M. H. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160340.72641.87 · Cited by 575
Soluble P-Selectin and the Risk of Future Cardiovascular Events
Ridker, P. M., Buring, J. E., & Rifai, N. (2001) · Circulation · doi:10.1161/01.cir.103.4.491 · Cited by 564
Zhou, X., Nicoletti, A., Elhage, R., & Hansson, G. K. (2000) · Circulation · doi:10.1161/01.cir.102.24.2919 · Cited by 554
Modulation of atherosclerosis in mice by Toll-like receptor 2
Mullick, A. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25482 · Cited by 549
A Crucial Role of Glycoprotein VI for Platelet Recruitment to the Injured Arterial Wall In Vivo
Massberg, S., Gawaz, M., Grüner, S., Schulte, V., Konrad, I., Zohlnhöfer, D., Heinzmann, U., & Nieswandt, B. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20020945 · Cited by 516
Junctional adhesion molecules (JAMs): more molecules with dual functions?
Ebnet, K., Suzuki, A., Ohno, S., & Vestweber, D. (2004) · Journal of Cell Science · doi:10.1242/jcs.00930 · Cited by 501
A human T cell-specific molecule is a member of a new gene family.
Schall, T. J., Jongstra, J., Dyer, B. J., Jorgensen, J., Clayberger, C., Davis, M. M., & Krensky, A. M. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.3.1018 · Cited by 495
Platelets express functional Toll-like receptor-4
Andonegui, G., Kerfoot, S. M., McNagny, K., Ebbert, K. V. J., Patel, K. D., & Kubes, P. (2005) · Blood · doi:10.1182/blood-2005-03-0916 · Cited by 491
Aslam, R., Speck, E. R., Kim, M., Crow, A. R., Bang, K. W. A., Nestel, F. P., Ni, H., Lazarus, A. H., Freedman, J., & Semple, J. W. (2006) · Blood · doi:10.1182/blood-2005-06-2202 · Cited by 488
Decreased atherosclerosis in CX3CR1–/– mice reveals a role for fractalkine in atherogenesis
Lesnik, P., Haskell, C. A., & Charo, I. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15555 · Cited by 487
Decreased Atherosclerotic Lesion Formation in CX3CR1/Apolipoprotein E Double Knockout Mice
Combadière, C., Potteaux, S., Gao, J.-L., Esposito, B., Casanova, S., Lee, E. J., Debré, P., Tedgui, A., Murphy, P. M., & Mallat, Z. (2003) · Circulation · doi:10.1161/01.cir.0000057548.68243.42 · Cited by 476
Walther, D. J., Peter, J.-U., Winter, S., Höltje, M., Paulmann, N., Grohmann, M., Vowinckel, J., Alamo-Bethencourt, V., Wilhelm, C. S., Ahnert-Hilger, G., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)01014-6 · Cited by 475
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis
Angelillo-Scherrer, A., de Frutos, P. G., Aparicio, C., Melis, E., Savi, P., Lupu, F., Arnout, J., Dewerchin, M., Hoylaerts, M. F., Herbert, J.-M., et al. (2001) · Nature Medicine · doi:10.1038/84667 · Cited by 441 · cited 1×
“During platelet activation, both growth-arrest-specific gene 6 (GAS6) and CD40 ligand (CD40L) are present in the platelet-platelet synapse and enhance stabilisation (31, 32).”
BackgroundKoenen, R. R., von Hundelshausen, P., Nesmelova, I. V., Zernecke, A., Liehn, E. A., Sarabi, A., Kramp, B. K., Piccinini, A. M., Paludan, S. R., Kowalska, M. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1898 · Cited by 440
Requirement for CD154 in the progression of atherosclerosis
Lutgens, E., Gorelik, L., Daemen, M. J. A. P., de Muinck, E. D., Grewal, I. S., Koteliansky, V. E., & Flavell, R. A. (1999) · Nature Medicine · doi:10.1038/15271 · Cited by 439
Santoso, S., Sachs, U. J. H., Kroll, H., Linder, M., Ruf, A., Preissner, K. T., & Chavakis, T. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020267 · Cited by 427
Bizzozero, J. (1882) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01931360 · Cited by 420
Antiplatelet therapies for the treatment of cardiovascular disease
Michelson, A. D. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2957 · Cited by 407
Siess, W., Zangl, K. J., Essler, M., Bauer, M., Brandl, R., Corrinth, C., Bittman, R., Tigyi, G., & Aepfelbacher, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6931 · Cited by 404
Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice
Veillard, N. R., Kwak, B., Pelli, G., Mulhaupt, F., James, R. W., Proudfoot, A. E. I., & Mach, F. (2004) · Circulation Research · doi:10.1161/01.res.0000109793.17591.4e · Cited by 377
Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium
von Hundelshausen, P., Koenen, R. R., Sack, M., Mause, S. F., Adriaens, W., Proudfoot, A. E. I., Hackeng, T. M., & Weber, C. (2005) · Blood · doi:10.1182/blood-2004-06-2475 · Cited by 373
Zhang, G., Han, J., Welch, E. J., Ye, R. D., Voyno-Yasenetskaya, T. A., Malik, A. B., Du, X., & Li, Z. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802884 · Cited by 363
Increased Platelet Binding to Circulating Monocytes in Acute Coronary Syndromes
Sarma, J., Laan, C. A., Alam, S., Jha, A., Fox, K. A. A., & Dransfield, I. (2002) · Circulation · doi:10.1161/01.cir.0000015700.27754.6f · Cited by 362
Structure and function of the platelet integrin IIb 3
Bennett, J. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26989 · Cited by 358
Schober, A., Manka, D., von Hundelshausen, P., Huo, Y., Hanrath, P., Sarembock, I. J., Ley, K., & Weber, C. (2002) · Circulation · doi:10.1161/01.cir.0000028590.02477.6f · Cited by 355
León-Ponte, Ahern, G. P., & O'Connell, P. J. (2007) · Blood · doi:10.1182/blood-2006-10-052787 · Cited by 347
Bao, W., Bussel, J. B., Heck, S., He, W., Karpoff, M., Boulad, N., & Yazdanbakhsh, K. (2010) · Blood · doi:10.1182/blood-2010-04-281717 · Cited by 345
CD40 Is Constitutively Expressed on Platelets and Provides a Novel Mechanism for Platelet Activation
Inwald, D. P., McDowall, A., Peters, M. J., Callard, R. E., & Klein, N. J. (2003) · Circulation Research · doi:10.1161/01.res.0000070111.98158.6c · Cited by 333
Genetic Variant of the Scavenger Receptor BI in Humans
Vergeer, M., Korporaal, S. J. A., Franssen, R., Meurs, I., Out, R., Hovingh, G. K., Hoekstra, M., Sierts, J. A., Dallinga-Thie, G. M., Motazacker, M. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0907687 · Cited by 317
Lutgens, E., Gijbels, M., Smook, M., Heeringa, P., Gotwals, P., Koteliansky, V. E., & Daemen, M. J. A. P. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000019729.39500.2f · Cited by 313
Platelets in defense against bacterial pathogens
Yeaman, M. R. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0210-4 · Cited by 303
Andrade, C., Sandarsh, S., Chethan, K. B., & Nagesh, K. S. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09r05786blu · Cited by 302
Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis
Lievens, D., Zernecke, A., Seijkens, T., Soehnlein, O., Beckers, L., Munnix, I. C. A., Wijnands, E., Goossens, P., van Kruchten, R., Thevissen, L., et al. (2010) · Blood · doi:10.1182/blood-2010-01-261206 · Cited by 301
Self-citationvan Gils, J. M., Zwaginga, J. J., & Hordijk, P. L. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0708400 · Cited by 298
Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets
Clemetson, K. J., Clemetson, J. M., Proudfoot, A. E. I., Power, C. A., Baggiolini, M., & Wells, T. N. C. (2000) · Blood · doi:10.1182/blood.v96.13.4046 · Cited by 271
Platelet-derived serotonin links vascular disease and tissue fibrosis
Dees, C., Akhmetshina, A., Zerr, P., Reich, N., Palumbo, K., Horn, A., Jüngel, A., Beyer, C., Krönke, G., Zwerina, J., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101629 · Cited by 266
Prominent Role of P-Selectin in the Development of Advanced Atherosclerosis in ApoE-Deficient Mice
Dong, Z. M., Brown, A. A., & Wagner, D. D. (2000) · Circulation · doi:10.1161/01.cir.101.19.2290 · Cited by 263
Naik, U. P., Patel, P. M., & Parise, L. V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.8.4651 · Cited by 259
Gawaz, M., Brand, K., Dickfeld, T., Pogatsa-Murray, G., Page, S., Bogner, C., Koch, W., Schömig, A., & Neumann, F.-J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00241-5 · Cited by 258
Hermann, A., Rauch, B. H., Braun, M., Schrör, K., & Weber, A.-A. (2001) · Platelets · doi:10.1080/09537100020031207 · Cited by 255
Platelet–Leukocyte Interactions in Cardiovascular Disease and Beyond
Totani, L., & Evangelista, V. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207480 · Cited by 251
Platelet thrombin receptor antagonism and atherothrombosis
Angiolillo, D. J., Capodanno, D., & Goto, S. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp504 · Cited by 251
Cyrus, T., Sung, S., Zhao, L., Funk, C. D., Tang, S., & Praticò, D. (2002) · Circulation · doi:10.1161/01.cir.0000027816.54430.96 · Cited by 247
Lutgens, E., Lievens, D., Beckers, L., Wijnands, E., Soehnlein, O., Zernecke, A., Seijkens, T., Engel, D., Cleutjens, J., Keller, A. M., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091293 · Cited by 246
Self-citationMassberg, S., Enders, G., Matos, F. C. D. M., Tomic, L. I. D., Leiderer, R., Eisenmenger, S., Messmer, K., & Krombach, F. (1999) · Blood · doi:10.1182/blood.v94.11.3829 · Cited by 241
Paul-Clark, M. J., van Cao, T., Moradi-Bidhendi, N., Cooper, D., & Gilroy, D. W. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040566 · Cited by 236
Bergmeier, W., Piffath, C. L., Goerge, T., Cifuni, S. M., Ruggeri, Z. M., Ware, J., & Wagner, D. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608207103 · Cited by 233
Platelet Granule Secretion Continuously Prevents Intratumor Hemorrhage
Ho-Tin-Noé, B., Goerge, T., Cifuni, S. M., Duerschmied, D., & Wagner, D. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0718 · Cited by 229
Duffau, P., Seneschal, J., Nicco, C., Richez, C., Lazaro, E., Douchet, I., Bordes, C., Viallard, J.-F., Goulvestre, C., Pellegrin, J.-L., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001001 · Cited by 222
Cipollone, F., Mezzetti, A., Porreca, E., Di Febbo, C., Nutini, M., Fazia, M., Falco, A., Cuccurullo, F., & Davì, G. (2002) · Circulation · doi:10.1161/01.cir.0000025419.95769.f0 · Cited by 216
Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism
Kaplanski, G., Farnarier, C., Kaplanski, S., Porat, R., Shapiro, L., Bongrand, P., & Dinarello, C. (1994) · Blood · doi:10.1182/blood.v84.12.4242.bloodjournal84124242 · Cited by 209
Early Atherosclerosis Exhibits an Enhanced Procoagulant State
Borissoff, J. I., Heeneman, S., Kilinç, E., Kaššák, P., Van Oerle, R., Winckers, K., Govers-Riemslag, J. W. P., Hamulyák, K., Hackeng, T. M., Daemen, M. J. A. P., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.907121 · Cited by 208
Dole, V. S., Bergmeier, W., Mitchell, H. A., Eichenberger, S. C., & Wagner, D. D. (2005) · Blood · doi:10.1182/blood-2005-04-1530 · Cited by 203
Senzel, L., Gnatenko, D. V., & Bahou, W. F. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32832e9dc6 · Cited by 202
MERHISOUSSI, F., KWAK, B., MAGNE, D., CHADJICHRISTOS, C., BERTI, M., PELLI, G., JAMES, R., MACH, F., & GABAY, C. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.01.008 · Cited by 200
Signaling through GP Ib-IX-V activates αIIbβ3 independently of other receptors
Kasirer-Friede, A., Cozzi, M. R., Mazzucato, M., De Marco, L., Ruggeri, Z. M., & Shattil, S. J. (2004) · Blood · doi:10.1182/blood-2003-10-3664 · Cited by 194
Toma, I., & McCaffrey, T. A. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1189-3 · Cited by 193
Danese, S., de la Motte, C., Reyes, B. M. R., Sans, M., Levine, A. D., & Fiocchi, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2011 · Cited by 189
Wang, Y., Sakuma, M., Chen, Z., Ustinov, V., Shi, C., Croce, K., Zago, A. C., Lopez, J., Andre, P., Plow, E., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.571315 · Cited by 183
Pitsilos, S., Hunt, J., Mohler, E., Prabhakar, A., Poncz, M., Dawicki, J., Khalapyan, T., L.Wolfe, M., Fairman, R., Mitchell, M., et al. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-02-0069 · Cited by 182
Effects of serotonin on platelet activation in whole blood
Li, N., Wall??n, N. H., Ladjevardi, M., & Hjemdahl, P. (1997) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199711000-00006 · Cited by 177
Kornerup, K. N., Salmon, G. P., Pitchford, S. C., Liu, W. L., & Page, C. P. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01086.2009 · Cited by 173
Platelet‐derived CXC chemokines: old players in new games
Brandt, E., Ludwig, A., Petersen, F., & Flad, H. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17705.x · Cited by 172
Fujisawa, T., Fujisawa, R., Kato, Y., Nakayama, T., Morita, A., Katsumata, H., Nishimori, H., Iguchi, K., Kamiya, H., Gray, P. W., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.126079 · Cited by 170
Müller, T., Dürk, T., Blumenthal, B., Grimm, M., Cicko, S., Panther, E., Sorichter, S., Herouy, Y., Di Virgilio, F., Ferrari, D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006453 · Cited by 170
Therapeutic targeting of chemokine interactions in atherosclerosis
Koenen, R. R., & Weber, C. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3048 · Cited by 153
Maßberg, S., Schürzinger, K., Lorenz, M. C., Konrad, I., Schulz, C., Plesnila, N., Kennerknecht, E., Rudelius, M., Sauer, S., Braun, S., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.539221 · Cited by 152
Platelets regulate CD4+ T-cell differentiation via multiple chemokines in humans
Gerdes, N., Zhu, L., Ersoy, M., Hermansson, A., Hjemdahl, P., Hu, H., Hansson, G. K., & Li, N. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-01-0020 · Cited by 145
The multi-functionality of CD40L and its receptor CD40 in atherosclerosis
Lievens, D., Eijgelaar, W. J., Biessen, E. A. L., Daemen, M. J. A. P., & Lutgens, E. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-01-0029 · Cited by 137
Self-citationImpact of glycoprotein VI and platelet adhesion on atherosclerosis—A possible role of fibronectin
Bültmann, A., Li, Z., Wagner, S., Peluso, M. V., Schönberger, T., Weis, C., Konrad, I., Stellos, K., Maßberg, S., Nieswandt, B., et al. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.04.009 · Cited by 135
Steinhubl, S. R., Badimón, J. J., Bhatt, D. L., Herbert, J., & Lüscher, T. F. (2007) · Vascular Medicine · doi:10.1177/1358863x07077462 · Cited by 134
Clopidogrel inhibits platelet-leukocyte adhesion and plateletdependent leukocyte activation
Manarini, S., Dell’Elba, G., Martelli, N., Napoleone, E., Santo, A. D., Savi, P., Lorenzet, R., & Evangelista, V. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-01-0020 · Cited by 134
Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion
Schäfer, A., Schulz, C., Eigenthaler, M., Fraccarollo, D., Kobsar, A. L., Gawaz, M., Ertl, G., Walter, U., & Bauersachs, J. K. (2003) · Blood · doi:10.1182/blood-2002-10-3260 · Cited by 132
Platelets as immune mediators: Their role in host defense responses and sepsis
Li, Z., Yang, F., Dunn, S., Gross, K., & Smyth, S. S. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.10.010 · Cited by 132
Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis
Siegel-Axel, D. I., Daub, K., Seizer, P., Lindemann, S., & Gawaz, M. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn015 · Cited by 129
Yeaman, M. R., Puentes, S. M., Norman, D. C., & Bayer, A. S. (1992) · Infection and Immunity · doi:10.1128/iai.60.3.1202-1209.1992 · Cited by 128
Serotonin Activates Human Monocytes and Prevents Apoptosis
Soga, F., Katoh, N., Inoue, T., & Kishimoto, S. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700824 · Cited by 124
Platelet Adhesion Receptors and Their Ligands in Mouse Models of Thrombosis
Denis, C. V., & Wagner, D. D. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000259359.52265.62 · Cited by 123
Phenotypic and Functional Evidence for the Expression of CXCR4 Receptor During Megakaryocytopoiesis
Rivière, C., Subra, F., Cohen-Solal, K., Cordette-Lagarde, V., Letestu, R., Auclair, C., Vainchenker, W., & Louache, F. (1999) · Blood · doi:10.1182/blood.v93.5.1511 · Cited by 122
Molecular Regulation of Platelet-Dependent Thrombosis
Freedman, J. E. (2005) · Circulation · doi:10.1161/circulationaha.104.494468 · Cited by 112
Lutgens, E., Faber, B., Schapira, K., Evelo, C. T., van Haaften, R. I. M., Heeneman, S., Cleutjens, K. B. J. M., Bijnens, A. P., Beckers, L., Porter, J. G., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.510073 · Cited by 110
Karshovska, E., Zernecke, A., Sevilmis, G., Millet, A., Hristov, M., Cohen, C. D., Schmid, H., Krötz, F., Sohn, H., Klauß, V., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.151050 · Cited by 102
Kisucka, J., Chauhan, A. K., Zhao, B., Patten, I. S., Yesilaltay, A., Krieger, M., & Wagner, D. D. (2009) · Blood · doi:10.1182/blood-2008-10-186650 · Cited by 101
Goto, S., Tamura, N., Ishida, H., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.055 · Cited by 100
Malergue, F., Galland, F., Martin, F. M., Mansuelle, P., Aurrand‐Lions, M., & Naquet, P. (1998) · Molecular Immunology · doi:10.1016/s0161-5890(98)00102-3 · Cited by 97
Gawaz, M., Stellos, K., & Langer, H. F. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02867.x · Cited by 93
Munnix, I. C. A., Strehl, A., Kuijpers, M. J. E., Auger, J. M., van der Meijden, P. E. J., van Zandvoort, M. A. M. J., Egbrink, M. G. A. O., Nieswandt, B., & Heemskerk, J. W. M. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000193568.71980.4a · Cited by 91
Chen, C., Chai, H., Wang, X., Jiang, J., Jamaluddin, M. S., Liao, D., Zhang, Y., Wang, H., Bharadwaj, U., Zhang, S., et al. (2008) · Blood · doi:10.1182/blood-2008-03-143479 · Cited by 90
The immunobiology of CD154–CD40–TRAF interactions in atherosclerosis
Engel, D. A., Seijkens, T. T. P., Poggi, M., Sanati, M., Thevissen, L., Beckers, L., Wijnands, E., Lievens, D., & Lutgens, E. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.06.004 · Cited by 84
Self-citationDetection of Integrin αIIbβ3Clustering in Living Cells
Buensuceso, C. S., de Virgilio, M., & Shattil, S. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213234200 · Cited by 83
Stolla, M., Stefanini, L., Roden, R. C., Chavez, M., Hirsch, J. D., Greene, T. K., Ouellette, T. D., Maloney, S. F., Diamond, S. L., Poncz, M., et al. (2010) · Blood · doi:10.1182/blood-2010-07-297713 · Cited by 81
The novel atherosclerosis locus at 10q11 regulates plasma CXCL12 levels
Mehta, N. N., Li, M., William, D. A., Khera, A. V., DerOhannessian, S. L., Qu, L., Ferguson, J. F., McLaughlin, C., Shaikh, L. H., Shah, R., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr091 · Cited by 80
Zernecke, A., Liehn, E. A., Fraemohs, L., von Hundelshausen, P., Koenen, R. R., Corada, M., Dejana, E., & Weber, C. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000197852.24529.4f · Cited by 78
Self-citationYacoub, D., Hachem, A., Théorêt, J., Gillis, M., Mourad, W. M., & Merhi, Y. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.216143 · Cited by 78
Korporaal, S. J. A., Meurs, I., Hauer, A. D., Hildebrand, R. B., Hoekstra, M., Cate, H. T., Praticò, D., Akkerman, J. N., van Berkel, T. J. C., Kuiper, J., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.210252 · Cited by 78
Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia
Ma, Y., Ashraf, M. Z., & Podrez, E. A. (2010) · Blood · doi:10.1182/blood-2010-02-268508 · Cited by 76
Yeaman, M. R., Norman, D. C., & Bayer, A. S. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.8.1665 · Cited by 71
Kasper, B., Brandt, E., Bulfone‐Paus, S., & Petersen, F. (2003) · Blood · doi:10.1182/blood-2003-08-2802 · Cited by 70
CD36 as a Multiple-Ligand Signaling Receptor in Atherothrombosis
Nergiz‐Unal, R., Rademakers, T., Cosemans, J. M. E. M., & Heemskerk, J. W. M. (2011) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152511794182855 · Cited by 70
Bergmeier, W., Piffath, C. L., Goerge, T., Cifuni, S. M., Ruggeri, Z. M., Ware, J. L., & Wagner, D. D. (2006) · Blood · doi:10.1182/blood.v108.11.1797.1797 · Cited by 68
Shpilberg, O., Rabi, I. A., Schiller, K., Walden, R. F. O., Harats, D., Tyrrell, K. S., Coller, B. S., & Seligsohn, U. (2002) · Circulation · doi:10.1161/hc0902.104676 · Cited by 59
Korporaal, S. J. A., Relou, I. A. M., Eck, M. V., Strasser, V., Bezemer, M., Gorter, G., van Berkel, T. J. C., Nimpf, J., Akkerman, J. N., & Lenting, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407407200 · Cited by 58
Antiplatelet Drugs – Do We Need New Options? With a Reappraisal of Direct Thromboxane Inhibitors
COCCHERI, S. (2010) · Drugs · doi:10.2165/11536000-000000000-00000 · Cited by 51
Association of the platelet GPIIb/IIIa polymorphism with atherosclerotic plaque morphology
Kucharska‐Newton, A., Monda, K. L., Campbell, S., Bradshaw, P. T., Wagenknecht, L. E., Boerwinkle, E., Wasserman, B. A., & HEISS, G. M. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.01.038 · Cited by 51
Duerschmied, D., Canault, M., Lievens, D., Brill, A. G., Cifuni, S. M., Bäder, M., & Wagner, D. D. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03476.x · Cited by 50
Self-citationAfek, A. B., Kogan, E., Maysel-Auslender, S., Mor, A., Regev, E., Rubinstein, A., Keren, G., & George, J. (2009) · Microvascular Research · doi:10.1016/j.mvr.2009.01.009 · Cited by 48
Optimal Management of Combined Dyslipidemia: What Have We Behind Statins Monotherapy?
Tenenbaum, A., Fisman, E. Z., Motro, M., & Adler, Y. (2008) · Advances in cardiology · doi:10.1159/000115192 · Cited by 44
Heterophilic chemokine receptor interactions in chemokine signaling and biology
Kramp, B. K., Sarabi, A., Koenen, R. R., & Weber, C. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.11.014 · Cited by 42
Liu, H., Jiang, D., Zhang, S., & Ou, B. (2009) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-009-6210-7 · Cited by 42
dos Santos, S. M., Klinkhardt, U., Scholich, K., Nelson, K., Monsefi, N., Deckmyn, H., Kuczka, K., Zorn, A., & Harder, S. (2011) · Blood · doi:10.1182/blood-2011-02-335471 · Cited by 39
Toll-Like Receptors, Their Ligands, and Atherosclerosis
Hodgkinson, C. P., & Ye, S. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.36 · Cited by 35
Interleukin-1α As a Factor in Occlusive Vascular Disease
Brody, J. I., Pickering, N. J., Capuzzi, D. M., Fink, G. B., Can, C. A., & Gomez, F. (1992) · American Journal of Clinical Pathology · doi:10.1093/ajcp/97.1.8 · Cited by 33
Low-Density Lipoprotein-Lowering Medication and Platelet Function
Ferroni, P., Basili, S., Santilli, F., & Davì, G. (2006) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000093226 · Cited by 31
Kiechl, S. J., Laxton, R. C., Xiao, Q., Hernesniemi, J. A., Raitakari, O. T., Kähönen, M. A. P., Mayosi, B. M., Jula, A., Moilanen, L., Willeit, J., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.213785 · Cited by 30
Assinger, A., Koller, F., Schmid, W., Zellner, M., Koller, E., & Volf, I. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.07.018 · Cited by 27
Tous, M., Ferré, N., Vilella, E., Riu, F., Camps, J., & Joven, J. (2004) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2004.pto950104.x · Cited by 25
Pharmacogenetics: Promise and Potential in Child and Adolescent Psychiatry
Anderson, G. M., & Cook, E. H. (2000) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30134-2 · Cited by 24
Cited by
Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans
Libby, P., Lichtman, A. H., & Hansson, G. K. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.009 · Cited by 671
Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
Vijay, K. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.002 · Cited by 643
Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?
Engelen, S. E., Robinson, A. J. B., Zurke, Y.-X., & Monaco, C. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00668-4 · Cited by 425
New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis
Wu, M.-Y., Li, C.-J., Hou, M.-F., & Chu, P.-Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102034 · Cited by 392
New Concepts and Mechanisms of Platelet Activation Signaling
Estevez, B., & Du, X. (2017) · Physiology · doi:10.1152/physiol.00020.2016 · Cited by 376
Metadata
- Authors
- Hundelshausen, P. V., & Lievens, D.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2011
- Volume
- 106
- Issue
- 11
- Pages
- 827-838
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2145007557
- Cited by
- 271
- References
- 145
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.